Ming Shi

Apr 20, 2024 | nature.com | Ming Shi |Hongming Huang |Dan Liu |Zhiling Yan |Wei Sang |Kunming Qi | +9 more

AbstractDespite the high therapeutic response achieved with B-cell maturation antigen (BCMA)-specific chimeric antigen receptor (CAR) T-cell therapy in relapsed and refractory multiple myeloma (R/R MM), primary resistance and relapse exist with single-target immunotherapy. Here, we design bispecific BC19 CAR T cells targeting BCMA/CD19 and evaluate antimyeloma activity in vitro and in vivo.

Apr 16, 2024 | epjap.epj.org | Ming Shi |South-Central Minzu |Weimin Zhang |Ling Wang

Eur. Phys. J. Appl. Phys.

Mar 1, 2024 | headachejournal.onlinelibrary.wiley.com | Lily Zhang |Yuting Fang |Liu Yang |Ming Shi

CONFLICT OF INTEREST STATEMENT Quan Gan, Lily Zhang, Yuting Fang, Liu Yang, Ming Shi, and Zheman Xiao declare no conflicts of interest. Supporting Information Filename Description head14688-sup-0001-TableS1.docxWord 2007 document , 12.7 KB Table S1.. REFERENCES 1, . Treatment of central nervous system complications of renal dialysis and transplantation. Curr Treat Options Neurol. 2019; 21(3): 13. doi:10.1007/s11940-019-0553-6 2, .